John D. Ulm

Array ( [id] => 9720944 [patent_doc_number] => 20140256645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'EXTRACT AND PEPTIDES DERIVED FROM ORYZA SATIVA JAPONICA GROUP AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/280689 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14516 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14280689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9719716 [patent_doc_number] => 20140255415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'LINGO Binding Molecules and Pharmaceutical Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/280933 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23497 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14280933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10755022 [patent_doc_number] => 20160101174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'LENTIVIRAL VECTORS WITH TROPISM TO MOTOR NEURONS COMPRISING AN ANTIBODY THAT BINDS TO A PRE-SYNAPTIC TERMINAL RECEPTOR ON THE NEUROMUSCULAR JUNCTION AND A FUSOGENIC PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/890869 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9042 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10912804 [patent_doc_number] => 20140315823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'PEPTIDE COMPOUNDS FOR SUPPRESSING INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 14/278643 [patent_app_country] => US [patent_app_date] => 2014-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13431 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14278643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11896303 [patent_doc_number] => 09766236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Taste receptor internalization assay' [patent_app_type] => utility [patent_app_number] => 14/890054 [patent_app_country] => US [patent_app_date] => 2014-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3609 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9686504 [patent_doc_number] => 20140243269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS' [patent_app_type] => utility [patent_app_number] => 14/271617 [patent_app_country] => US [patent_app_date] => 2014-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11996 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9686505 [patent_doc_number] => 20140243270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING NEUREGULIN ISOFORMS' [patent_app_type] => utility [patent_app_number] => 14/271749 [patent_app_country] => US [patent_app_date] => 2014-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12003 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10920388 [patent_doc_number] => 20140323408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'METHOD OF INHIBITING DOPAMINERGIC CELL DEATH' [patent_app_type] => utility [patent_app_number] => 14/271755 [patent_app_country] => US [patent_app_date] => 2014-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12005 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14271755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10761944 [patent_doc_number] => 20160108098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'THERAPEUTIC PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/888085 [patent_app_country] => US [patent_app_date] => 2014-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14322 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919232 [patent_doc_number] => 20140322250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'Peptides for the Treatment of Multiple Sclerosis and Related Diseases' [patent_app_type] => utility [patent_app_number] => 14/263493 [patent_app_country] => US [patent_app_date] => 2014-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7844 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14263493 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11657275 [patent_doc_number] => 09670264 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Water soluble G-protein coupled receptor' [patent_app_type] => utility [patent_app_number] => 14/786578 [patent_app_country] => US [patent_app_date] => 2014-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8484 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10728225 [patent_doc_number] => 20160074374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-17 [patent_title] => 'CORRECTORS ACTING THROUGH MSD1 OF CFTR PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/787061 [patent_app_country] => US [patent_app_date] => 2014-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 39376 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14787061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12255284 [patent_doc_number] => 09927424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-27 [patent_title] => 'Assays for identifying compounds that modulate bitter taste' [patent_app_type] => utility [patent_app_number] => 14/786876 [patent_app_country] => US [patent_app_date] => 2014-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 14 [patent_no_of_words] => 35864 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14786876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534883 [patent_doc_number] => 09260505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Methods for screening for binding partners of G-protein coupled receptors' [patent_app_type] => utility [patent_app_number] => 14/255939 [patent_app_country] => US [patent_app_date] => 2014-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 69 [patent_no_of_words] => 48635 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14255939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9771235 [patent_doc_number] => 20140294899 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'CYTOKINE BIOMARKERS AS PREDICTIVE BIOMARKERS OF CLINICAL RESPONSE FOR GLATIRAMER ACETATE' [patent_app_type] => utility [patent_app_number] => 14/250955 [patent_app_country] => US [patent_app_date] => 2014-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6655 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14250955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10136937 [patent_doc_number] => 09170254 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators' [patent_app_type] => utility [patent_app_number] => 14/243380 [patent_app_country] => US [patent_app_date] => 2014-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21892 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14243380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10699340 [patent_doc_number] => 20160045487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING NEUROPATHY' [patent_app_type] => utility [patent_app_number] => 14/780322 [patent_app_country] => US [patent_app_date] => 2014-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16856 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14780322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10687390 [patent_doc_number] => 20160033535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'Methods for the Diagnosis of Amyotrophic Lateral Sclerosis' [patent_app_type] => utility [patent_app_number] => 14/776347 [patent_app_country] => US [patent_app_date] => 2014-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11351 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10684260 [patent_doc_number] => 20160030406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'CORRECTORS ACTING THROUGH MSD1 OF CFTR PROTEIN' [patent_app_type] => utility [patent_app_number] => 14/776874 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31887 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10687336 [patent_doc_number] => 20160033481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'RE-TRAFFICKING OF HERG REVERSES LONG QT SYNDROME 2 PHENOTYPE IN HUMAN IPS-DERIVED CARDIOMYOCYTES' [patent_app_type] => utility [patent_app_number] => 14/776616 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 12405 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776616 [rel_patent_id] =>[rel_patent_doc_number] =>)